Active

Allero Therapeutics

Switched

BE0665757817

Rechtspersoon Private limited company 1 establishment

Onderstraat 7, 9000 Gent

Active for

9 year, 10 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ -2,308

▼ 1% vs 2024

Profit

Caution

€ -3,030

▼ 2570% vs 2024

Debts

Low

€ 10,015

▲ 16% vs 2024

Allero Therapeutics from Gent, company number BE0665757817, closed financial year 2025 with a result of € -3,030 after tax. For that financial year Allero Therapeutics recorded a gross margin of € -2,308 and equity of € 68,509. Compared with financial year 2024, the result moved from € 123 to € -3,030. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What happened at Allero Therapeutics?

What happened at Allero Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 3,030 (▼ 2570% vs 2024). Source: NBB ↗
  • New establishment in Gent. KBO
  • Start of the company according to the CBE. KBO
  • Emil POT became a director. NBB

In short

From € 14,471 loss in 2021 to € 3,030 loss in 2025.

Best year ever: 2022, with € 254,322 profit.

A new publication or filing at Allero Therapeutics? We notify you, reason included.

Follow Allero Therapeutics

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Emil POT
Allero Therapeutics
Allero Therapeutics 51.4%

Behind Allero Therapeutics is Emil POT. It owns 51.4% of Allero Therapeutics itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Emil POT

Director

Also active at: P & X Medical

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Onderstraat 7 box 211

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

Details

Company number
0665.757.817
VAT number
BE 0665.757.817
Registered office
Onderstraat 7 bus 211, 9000 Gent
Names & denominations
Allero Therapeutics
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 November 2016
Peppol
Active · Active since 6 Nov 2025

Frequently asked questions

What is the enterprise number of Allero Therapeutics?
The enterprise number of Allero Therapeutics is BE0665757817.
What is the address of Allero Therapeutics?
The registered office of Allero Therapeutics is located at Onderstraat 7 box 211, 9000 Gent.
When was Allero Therapeutics founded?
Allero Therapeutics was founded on 4 November 2016.
Does Allero Therapeutics have a website?
No website is currently known for Allero Therapeutics.
How much profit did Allero Therapeutics make in 2025?
Allero Therapeutics recorded a loss after taxes of € 3,030 in financial year 2025.
What is the revenue of Allero Therapeutics?
As a small company, Allero Therapeutics is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -2,308.
Where can I find the annual accounts of Allero Therapeutics?
Allero Therapeutics files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Allero Therapeutics?
According to the 2025 annual accounts, the directors of Allero Therapeutics are: Emil POT.
Who owns Allero Therapeutics?
Behind Allero Therapeutics is Emil POT. It owns 51.4% of Allero Therapeutics itself.